|
|
脂联素对慢性肾脏病的影响
|
Abstract:
| [1] | Palit, S.P., Patel, R., Jadeja, S.D., Rathwa, N., Mahajan, A., Ramachandran, A.V., Dhar, M.K., Sharma, S. and Begum, R. (2020) A Genetic Analysis Identifies a Haplotype at Adiponectin Locus: Association with Obesity and Type 2 Diabetes. Scientific Reports, 10, Article No. 2904. |
| [2] | Niu, M.M., Xiang, L., Liu, Y.Q., Zhao, Y.Q., Yuan, J.F., Dai, X. and Chen, H. (2017) Adiponectin Induced AMPK Impairment Mediates Insulin Resistance in Bama Mini-Pig Fed High-Fat and High-Sucrose Diet. Asian Australasian Journal of Animal Sciences, 30, 1190-1197. https://doi.org/10.1038/s41598-020-59845-z |
| [3] | 陈佩娜, 吴小燕, 梁姗姗, 等. 维持性血液透析患者脂联素与左室肥厚的相关性[J]. 武汉大学学报(医学版), 2019, 40(1): 116-120. |
| [4] | Zha, D.Q., Wu, X.Y. and Gao, P. (2017) Adiponectin and Its Receptors in Diabetic Kidney Disease: Molecular Mechanisms and Clinical Potential. Endocrinology, 158, 2022-2034. https://doi.org/10.1210/en.2016-1765 |
| [5] | Goto, M., Goto, A., Morita, A., et al. (2014) Low-Molecular-Weight Adiponectin and High-Molecular-Weight Adiponectin Levels in Relation to Diabetes. Obesity, 22, 401-407. https://doi.org/10.1002/oby.20553 |
| [6] | Kuo, I.C., Wu, P.H., Lin, H.Y.-H., Niu, S.-W., Huang, J.-C., Hung, C.-C., Chiu, Y.-W. and Chen, H.-C. (2019) The Association of Adiponectin with Metabolic Syndrome and Clinical Outcome in Patients with Non-Diabetic Chronic Kidney Disease. PLoS ONE, 14, e0220158. https://doi.org/10.1371/journal.pone.0220158 |
| [7] | Rhee, C.M., Nguyen, D.V., Moradi, H., Brunelli, S.M., et al. (2015) Association of Adiponectin with Body Composition and Mortality in Hemodialysis Patients. American Journal of Kidney Diseases, 66, 313-321.
https://doi.org/10.1053/j.ajkd.2015.02.325 |
| [8] | Tsigalou, C., Chalikias, G., Kantartzi, K., et al. (2013) Differential Effect of Baseline Adiponectin on All-Cause Mortality in Hemodialysis Patients Depending on Initial Body Mass Index. Long-Term Follow-Up Data of 4.5 Years. Journal of Renal Nutrition, 23, 45-56. https://doi.org/10.1053/j.jrn.2011.12.007 |
| [9] | Martinez Cantarin, M.P., Waldman, S.A., Doria, C., Frank, A.M., Maley, W.R., Ramirez, C.B., Keith, S.W. and Falkner, B. (2013) The Adipose Tissue Production of Adiponectin Is Increased in End-Stage Renal Disease. Kidney International, 83, 487-494. https://doi.org/10.1038/ki.2012.421 |
| [10] | Ohashi, K., Iwatani, H., Kihara, S., Nakagawa, Y., Komura, N., Fujita, K., Maeda, N., Nishida, M., Katsube, F., Shimomura, I., Ito, T. and Funahashi, T. (2007) Exacerbation of Albuminuria and Renal Fibrosis in Subtotal Renal Ablation Model of Adiponectin-Knockout Mice. Arteriosclerosis Thrombosis and Vascular Biology, 27, 1910-1917.
https://doi.org/10.1161/ATVBAHA.107.147645 |
| [11] | Sharma, K., Ramachandrarao, S., Qiu, G., et al. (2008) Adiponectin Regulates Albuminuria and Podocyte Function in Mice. Journal of Clinical Investigation, 118, 1645-1656. https://doi.org/10.1172/JCI32691 |
| [12] | Rutkowski, J.M., Wang, Z.V., Park, A.S.D., et al. (2013) Adiponectin Promotes Functional Recovery after Podocyte Ablation. Journal of the American Society of Nephrology, 24, 268-282. https://doi.org/10.1681/ASN.2012040414 |
| [13] | Yu, Y., Bao, B.J., Fan, Y.P., et al. (2014) Changes of Adiponectin and Its Receptors in Rats Following Chronic Renal Failure. Renal Failure, 36, 92-97. https://doi.org/10.3109/0886022X.2013.830975 |
| [14] | Christou, G.A. and Kiortsis, D.N. (2014) The Role of Adiponectin in Renal Physiology and Development of Albuminuria. Journal of Endocrinology, 221, R49-R61. https://doi.org/10.1530/JOE-13-0578 |
| [15] | Kim, H.Y., Bae, E.H., Ma, S.K., Chae, D.W., Choi, K.H., Kim, Y.-S., Hwang, Y.-H., Ahn, C. and Kim, S.W. (2016) Association of Serum Adiponectin Level with Albuminuria in Chronic Kidney Disease Patients. Clinical and Experimental Nephrology, 20, 443-449. https://doi.org/10.1007/s10157-015-1173-4 |
| [16] | Bulum, T., Vucic Lovrencic, M., Tomic, M., Vu？kovi？-Rebrina, S., Roso, V., Kolari？, B., Vuksan, V. and Duvnjak, L. (2019) Serum Adipocytokines Are Associated with Microalbuminuria in Patients with Type 1 Diabetes and Incipient Chronic Complications. Diabetes Metabolic Syndrome: Clinical Research Reviews, 13, 496-499.
https://doi.org/10.1016/j.dsx.2018.11.001 |
| [17] | Hashikawa-Hobara, N., Chan, Y.K. and Levi, R. (2012) Histamine 3 Receptor Activation Reduces the Expression of Neuronal Angiotensin II Type 1 Receptors in the Heart. Journal of Pharmacology and Experimental Therapeutics, 340, 185-191. https://doi.org/10.1124/jpet.111.187765 |
| [18] | Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O’Callaghan, C.A., Lasserson, D.S. and Richard Hobbs, F.D. (2016) Global Prevalence of Chronic Kidney Disease—A Systematic Review and Meta-Analysis. PLoS ONE, 11, e0158765.
https://doi.org/10.1371/journal.pone.0158765 |
| [19] | El-Shafey, E.M. and Shalan, M. (2014) Plasma Adiponectin Levels for Prediction of Cardiovascular Risk among Hemodialysis Patients. Therapeutic Apheresis and Dialysis, 18, 185-192.
https://doi.org/10.1111/1744-9987.12065 |
| [20] | Iwashima, Y., Horio, T., Kumada, M., et al. (2006) Adiponectin and Renal Function, and Implication as A Risk of Cardiovascular Disease. American Journal of Cardiology, 98, 1603-1608.
https://doi.org/10.1016/j.amjcard.2006.07.039 |
| [21] | Becker, B., Kronenberg, F., Kielstein, J.T., Haller, H., Morath, C., Ritz, E., Fliser, D. and for the MMKD Study Group (2005) Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease: The Mild and Moderate Kidney Disease Study. Journal of the American Society of Nephrology, 16, 1091-1098.
https://doi.org/10.1681/ASN.2004090742 |
| [22] | Abdallah, E., Waked, E., Nabil, M., et al. (2012) Adiponectin and Cardiovascular Outcomes among Hemodialysis Patients. Kidney Blood Pressure Research, 35, 247-253. https://doi.org/10.1159/000334649 |
| [23] | Menon, V., Li, L.J., Wang, X.L., Greene, T., et al. (2006) Adiponectin and Mortality in Patients with Chronic Kidney Disease. Journal of the American Society of Nephrology, 17, 2599-2606.
https://doi.org/10.1681/ASN.2006040331 |
| [24] | Von Eynatten, M., Liu, D., Hock, C., et al. (2009) Urinary Adiponectin Excretion: A Novel Marker for Vascular Damage in Type 2 Diabetes. Diabetes, 58, 2093-2099. https://doi.org/10.2337/db09-0204 |
| [25] | Zhan, J.K., Wang, Y., He, J.Y., Wang, Y.-J., Tan, P., Tang, Z.-Y., Deng, H.-Q., Huang, W. and Liu, Y-S. (2015) Artery Calcification, Osteoporosis, and Plasma Adiponectin Levels Inchinese Elderly. Heart & Lung, 44, 539-543.
https://doi.org/10.1016/j.hrtlng.2015.08.006 |
| [26] | Sakura, T., Okuno, S., Nishio, E., Norimine, K., Ishimura, E., Yamakawa, T., Shoji, S. and Inaba, M. (2017) The Association of Serum Adiponectin with Abdominal Aortic Calcification in Japanese Male Hemodialysis Patients: A Cross-Sectional Observational Study. Scientific Reports, 7, Article No. 6434. https://doi.org/10.1038/s41598-017-06850-4 |
| [27] | Hyun, Y.Y., Kim, H., Oh, Y.K., Oh, K.-H., Ahn, C., Sung, S.A., Choi, K.H., Kim, S.W. and Lee, K.-B. (2019) High Fibroblast Growth Factor 23 Is Associated with Coronary Calcification in Patients with High Adiponectin: Analysis from the Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease Study. Nephrology Dialysis Transplantation, 34, 123-129. https://doi.org/10.1093/ndt/gfy110 |
| [28] | Lewerin, C., Johansson, H., Lerner, U.H., Karlsson, M.K., Lorentzon, M., Barrett-Connor, E., Smith, U., Ohlsson, C. and Mellstr？m, D. (2015) High Serum Adiponectin Is Associated with Low Blood Haemoglobin in Elderly Men: The Swedish Mros Study. Journal of Internal Medicine, 278, 68-76. https://doi.org/10.1111/joim.12340 |
| [29] | Kohno, K., Narimatsu, H, Shiono, Y, et al. (2014) Management of Erythropoiesis: Cross-Sectional Study of the Relationships between Erythropoiesis and Nutrition, Physical Features, and Adiponectin in 3519 Japanese People. European Journal of Haematology, 92, 298-307. https://doi.org/10.1111/ejh.12250 |
| [30] | Kim, H., Yun, H.R., Park, S., et al. (2018) High Serum Adiponectin Is Associated with Anemia Development in Chronic Kidney Disease: The Results from the KNOW-CKD Study. Cytokine, 103, 1-9.
https://doi.org/10.1016/j.cyto.2017.12.018 |
| [31] | Cawthorn, W., Scheller, E., Learman, B., et al. (2014) Bone Marrow Adipose Tissue Is an Endocrine Organ That Contributes to Increased Circulating Adiponectin during Caloric Restriction. Cell Metabolism, 20, 368-375.
https://doi.org/10.1016/j.cmet.2014.06.003 |
| [32] | Moorthi, R.N., Fadel, W., Eckert, G.J., Ponsler-Sipes, K., Moe, S. M. and Lin, C. (2015) Bone Marrow Fat Is Increased in Chronic Kidney Disease by Magnetic Resonance Spectroscopy. Osteoporosis International, 26, 1801-1807.
https://doi.org/10.1007/s00198-015-3064-7 |
| [33] | Hyun, Y.Y., Lee, K.B., Oh, K.H., et al. (2017) Serum Adiponectin and Protein-Energy Wasting in Predialysis Chronic Kidney Disease. Nutrition, 33, 254-260. https://doi.org/10.1016/j.nut.2016.06.014 |
| [34] | Nagasu, H., Satoh, M., Kiyokage, E., et al. (2016) Activation of Endothelial NAD(P)H Oxidase Accelerates Early Glomerular Injury in Diabetic Mice. Laboratory Investigation, 96, 25-36. https://doi.org/10.1038/labinvest.2015.128 |
| [35] | Hu, J., Dong, J., Yang, Z., Wu, H. and Yang, N. (2017) Protective Effects of Adiponectin against Diabetic Renal Injury in a Mouse Model of Diabetes. Cellular Physiology and Biochemistry, 43, 870-878. https://doi.org/10.1159/000481612 |
| [36] | Kacso, I., Lenghel, A., Bondor, C.I., et al. (2012) Low Plasma Adiponectin Levels Predict Increased Urinary Albumin/Creatinine Ratio in Type 2 Diabetes Patients. International Urology and Nephrology , 44, 1151-1157.
https://doi.org/10.1007/s11255-011-0064-1 |
| [37] | Moreno, L.O., Salvemini, L., Mendonca, C., et al. (2015) Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes. PLoS ONE, 10, e0119529. https://doi.org/10.1371/journal.pone.0119529 |
| [38] | Panduru, N.M., Saraheimo, M., Forsblom, C., et al. (2015) Urinary Adiponectin Is an Independent Predictor of Progression to End-Stage Renal Disease in Patients with Type 1 Diabetes and Diabetic Nephropathy. Diabetes Care, 38, 883-890. https://doi.org/10.2337/dc14-2276 |
| [39] | Ha, K.H. and Kim, D.J. (2016) Urinary Adiponectin and Progression of Diabetic Nephropathy in Type 1 Diabetes. Journal of Diabetes Investigation, 7, 470-471. https://doi.org/10.1111/jdi.12427 |
| [40] | Yamamoto, M., Fujimoto, Y., Hayashi, S., et al. (2018) A Study of High, Middle and Low Molecular Weight Adiponectin in Urine as A Surrogate Marker for Early Diabetic Nephropathy Using Ultrasensitive Immune Complex Transfer Enzyme Immunoassay. Annals of Clinical Biochemistry, 55, 525-534.
https://doi.org/10.1177/0004563217748681 |
| [41] | Balducci, S., Zanuso, S., Nicolucci, A., et al. (2010) Anti-Inflammatory Effect of Exercise Training in Subjects with Type 2 Diabetes and the Metabolic Syndrome Is Dependent on Exercise Modalities and Independent of Weight Loss.Nutrition, Metabolism, and Cardiovascular Diseases: NMCD, 20, 608-617.
https://doi.org/10.1016/j.numecd.2009.04.015 |
| [42] | Navaneethan, S.D., Kelly, K.R., Sabbagh, F., et al. (2010) Urinary Albumin Excretion, HMW Adiponectin, and Insulin Sensitivity in Type 2 Diabetic Patients Undergoing Bariatric Surgery. Obesity Surgery, 20, 308-315.
https://doi.org/10.1007/s11695-009-0026-1 |
| [43] | Yamauchi, T., Iwabu, M., Okada-Iwabu, M., et al. (2014) Adiponectin Receptors: A Review of Their Structure, Function and How They Work. Best Practice Research Clinical Endocrinology Metabolism, 28, 15-23.
https://doi.org/10.1016/j.beem.2013.09.003 |
| [44] | Rojas, E., Rodríguez-Molina, D., Bolli, P., et al. (2014) The Role of Adiponectin in Endothelial Dysfunction and Hypertension. Current Hypertension Reports, 16, Article No. 463.
https://doi.org/10.1007/s11906-014-0463-7 |
| [45] | Kakuda, H., Kobayashi, J., Sakurai, M., et al. (2019) Residual Effect of Sodium Glucose Cotransporter 2 Inhibitor, Tofogliflozin, on Body Weight after Washout in Japanese Men with Type 2 Diabetes. Journal of Clinical Medicine Research, 11, 35-41. https://doi.org/10.14740/jocmr3650 |
| [46] | Tsunoda, F., Asztalos, I.B., Horvath, K.V., Steiner, G., Schaefer, E.J. and Asztalos, B.F. (2016) Fenofibrate, HDL, and Cardiovascular Disease in Type-2 Diabetes: The DAIS Trial. Atherosclerosis, 247, 35-39.
https://doi.org/10.1016/j.atherosclerosis.2016.01.028 |
